Ambit Biosciences

Description

Insight. Ambition. Innovation. Ambit Biosciences is combining the power of our KinomeScan kinase profiling technology with an innovative licensing strategy and a history of kinase expertise to discover, optimize and advance a sustainable pipeline of small molecule kinase inhibitors for the treatment of cancer.Ambit Biosciences is a privately-held biopharmaceutical company engaged in the discovery and development of small-molecule kinase inhibitors for the treatment of cancer.With more than 500 distinct kinases identified and over 30 kinase inhibitors in clinical trials or FDA approved, this important class of proteins is a rich area for therapeutic drug development. And Ambit Biosciences has the technology, the expertise and the vision to succeed in the kinase space.

Fact sheet

Company contacts

Companies nearby